247 related articles for article (PubMed ID: 35213554)
1. Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial.
Marseille E; Mitchell JM; Kahn JG
PLoS One; 2022; 17(2):e0263252. PubMed ID: 35213554
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD.
Marseille E; Kahn JG; Yazar-Klosinski B; Doblin R
PLoS One; 2020; 15(10):e0239997. PubMed ID: 33052965
[TBL] [Abstract][Full Text] [Related]
3. The Costs and Health Benefits of Expanded Access to MDMA-assisted Therapy for Chronic and Severe PTSD in the USA: A Modeling Study.
Avanceña ALV; Kahn JG; Marseille E
Clin Drug Investig; 2022 Mar; 42(3):243-252. PubMed ID: 35230652
[TBL] [Abstract][Full Text] [Related]
4. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331
[TBL] [Abstract][Full Text] [Related]
5. 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.
Ot'alora G M; Grigsby J; Poulter B; Van Derveer JW; Giron SG; Jerome L; Feduccia AA; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
J Psychopharmacol; 2018 Dec; 32(12):1295-1307. PubMed ID: 30371148
[TBL] [Abstract][Full Text] [Related]
6. The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.
Mithoefer MC; Wagner MT; Mithoefer AT; Jerome L; Doblin R
J Psychopharmacol; 2011 Apr; 25(4):439-52. PubMed ID: 20643699
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.
Jerome L; Feduccia AA; Wang JB; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
Psychopharmacology (Berl); 2020 Aug; 237(8):2485-2497. PubMed ID: 32500209
[TBL] [Abstract][Full Text] [Related]
8. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Mitchell JM; Bogenschutz M; Lilienstein A; Harrison C; Kleiman S; Parker-Guilbert K; Ot'alora G M; Garas W; Paleos C; Gorman I; Nicholas C; Mithoefer M; Carlin S; Poulter B; Mithoefer A; Quevedo S; Wells G; Klaire SS; van der Kolk B; Tzarfaty K; Amiaz R; Worthy R; Shannon S; Woolley JD; Marta C; Gelfand Y; Hapke E; Amar S; Wallach Y; Brown R; Hamilton S; Wang JB; Coker A; Matthews R; de Boer A; Yazar-Klosinski B; Emerson A; Doblin R
Nat Med; 2021 Jun; 27(6):1025-1033. PubMed ID: 33972795
[TBL] [Abstract][Full Text] [Related]
9. MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial.
Ching TH; Williams MT; Wang JB; Jerome L; Yazar-Klosinski B; Emerson A; Doblin R
J Psychopharmacol; 2022 Aug; 36(8):974-986. PubMed ID: 35727042
[TBL] [Abstract][Full Text] [Related]
10. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
Mithoefer MC; Feduccia AA; Jerome L; Mithoefer A; Wagner M; Walsh Z; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
Psychopharmacology (Berl); 2019 Sep; 236(9):2735-2745. PubMed ID: 31065731
[TBL] [Abstract][Full Text] [Related]
11. Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder.
Zeifman RJ; Kettner H; Ross S; Weiss B; Mithoefer MC; Mithoefer AT; Wagner AC
Eur J Psychotraumatol; 2024; 15(1):2297536. PubMed ID: 38174611
[TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).
Oehen P; Traber R; Widmer V; Schnyder U
J Psychopharmacol; 2013 Jan; 27(1):40-52. PubMed ID: 23118021
[TBL] [Abstract][Full Text] [Related]
13. Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder.
Ponte L; Jerome L; Hamilton S; Mithoefer MC; Yazar-Klosinski BB; Vermetten E; Feduccia AA
J Trauma Stress; 2021 Aug; 34(4):851-863. PubMed ID: 34114250
[TBL] [Abstract][Full Text] [Related]
14. MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis.
Smith KW; Sicignano DJ; Hernandez AV; White CM
J Clin Pharmacol; 2022 Apr; 62(4):463-471. PubMed ID: 34708874
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Telemedicine-Based Collaborative Care for Posttraumatic Stress Disorder.
Painter JT; Fortney JC; Austen MA; Pyne JM
Psychiatr Serv; 2017 Nov; 68(11):1157-1163. PubMed ID: 28669290
[TBL] [Abstract][Full Text] [Related]
16. A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis.
Illingworth BJ; Lewis DJ; Lambarth AT; Stocking K; Duffy JM; Jelen LA; Rucker JJ
J Psychopharmacol; 2021 May; 35(5):501-511. PubMed ID: 33345689
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.
Feduccia AA; Jerome L; Mithoefer MC; Holland J
Psychopharmacology (Berl); 2021 Feb; 238(2):581-588. PubMed ID: 33221932
[TBL] [Abstract][Full Text] [Related]
18. Posttraumatic Growth After MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder.
Gorman I; Belser AB; Jerome L; Hennigan C; Shechet B; Hamilton S; Yazar-Klosinski B; Emerson A; Feduccia AA
J Trauma Stress; 2020 Apr; 33(2):161-170. PubMed ID: 32073177
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
Wagner MT; Mithoefer MC; Mithoefer AT; MacAulay RK; Jerome L; Yazar-Klosinski B; Doblin R
J Psychopharmacol; 2017 Aug; 31(8):967-974. PubMed ID: 28635375
[TBL] [Abstract][Full Text] [Related]
20. Cost Effectiveness Analysis of Tisagenlecleucel for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma in Japan.
Wakase S; Teshima T; Zhang J; Ma Q; Fujita T; Yang H; Chai X; Qi CZ; Liu Q; Wu EQ; Igarashi A
Transplant Cell Ther; 2021 Jun; 27(6):506.e1-506.e10. PubMed ID: 33823168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
